Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06360601
PHASE1/PHASE2
Intravenous Labetalol Versus Hydralazine in Preeclampsia
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
We study the effect of intravenous labetalol versus hydralazine in sever preeclampsia patients on cerebral blood flow and neurological outcome
Official title: The Effect of Intravenous Infusion of Labetalol Versus Hydralazine on Cerebral Hemodynamics of Preeclampsia Patients Prospective Randamized Study
Key Details
Gender
FEMALE
Age Range
25 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-04-01
Completion Date
2024-12-20
Last Updated
2024-12-02
Healthy Volunteers
No
Conditions
Interventions
DRUG
Labetalol Injection
Labetalol intravenous infusion 20ml/hr
DRUG
HydrALAZINE Injection
Hydralazine intravenous infusion 5mg/hr
Locations (1)
Tanta Univeristy hospitals
Tanta, Egypt